S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
Log in

NYSE:THCTenet Healthcare Stock Price, Forecast & News

$29.30
+0.05 (+0.17 %)
(As of 08/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$28.44
Now: $29.30
$29.39
50-Day Range
$16.81
MA: $22.35
$29.75
52-Week Range
$10.00
Now: $29.30
$39.37
Volume1.05 million shs
Average Volume2.18 million shs
Market Capitalization$3.09 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.48
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; physical therapy, orthopedic, oncology, and outpatient services; cardiothoracic surgery, neonatal intensive care, and neurosurgery services; quaternary care in heart, liver, kidney, and bone marrow transplants areas; tertiary and quaternary pediatric, and burn services; and limb-salvaging vascular procedures, acute level 1 trauma services, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, and telemedicine access for various medical specialties. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, and surgical hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, as well as value-based care solutions to healthcare systems, individual hospitals, physician practices, self-insured organizations, health plans, and other entities. As of December 31, 2018, the company operated 68 hospitals, 23 surgical hospitals, and approximately 475 outpatient centers, as well as 255 ambulatory surgery, 36 urgent care, and 23 imaging centers in the United States. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
Read More
Tenet Healthcare logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.2Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.21 out of 5 stars


Industry, Sector and Symbol

Industry General medical & surgical hospitals
Sub-IndustryHealth Care Facilities
SectorMedical
CUSIP88033G40
Phone469-893-2200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$18.48 billion
Cash Flow$11.31 per share
Book Value$4.65 per share

Profitability

Net Income$-232,000,000.00

Miscellaneous

Employees113,600
Market Cap$3.09 billion
Next Earnings Date11/2/2020 (Estimated)
OptionableOptionable
$29.30
+0.05 (+0.17 %)
(As of 08/13/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive THC News and Ratings via Email

Sign-up to receive the latest news and ratings for THC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Tenet Healthcare (NYSE:THC) Frequently Asked Questions

How has Tenet Healthcare's stock been impacted by Coronavirus (COVID-19)?

Tenet Healthcare's stock was trading at $19.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, THC shares have increased by 46.6% and is now trading at $29.30.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Tenet Healthcare?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tenet Healthcare in the last year. There are currently 6 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Tenet Healthcare
.

When is Tenet Healthcare's next earnings date?

Tenet Healthcare is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Tenet Healthcare
.

How were Tenet Healthcare's earnings last quarter?

Tenet Healthcare Corp (NYSE:THC) released its earnings results on Monday, August, 3rd. The company reported $1.26 EPS for the quarter, topping the consensus estimate of ($0.71) by $1.97. The firm had revenue of $3.65 billion for the quarter, compared to analysts' expectations of $3.83 billion. Tenet Healthcare had a positive return on equity of 82.35% and a negative net margin of 0.28%. The firm's revenue was down 20.0% compared to the same quarter last year. During the same period last year, the company earned $0.65 earnings per share.
View Tenet Healthcare's earnings history
.

What price target have analysts set for THC?

11 equities research analysts have issued 1 year price targets for Tenet Healthcare's shares. Their forecasts range from $22.00 to $35.00. On average, they expect Tenet Healthcare's stock price to reach $28.91 in the next twelve months. This suggests that the stock has a possible downside of 1.3%.
View analysts' price targets for Tenet Healthcare
.

Has Tenet Healthcare been receiving favorable news coverage?

Media headlines about THC stock have been trending negative this week, according to InfoTrie Sentiment. The research group ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Tenet Healthcare earned a media sentiment score of -2.4 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days.
View the latest news about Tenet Healthcare
.

Are investors shorting Tenet Healthcare?

Tenet Healthcare saw a decline in short interest in July. As of July 31st, there was short interest totaling 8,890,000 shares, a decline of 5.9% from the July 15th total of 9,450,000 shares. Based on an average daily volume of 2,250,000 shares, the short-interest ratio is currently 4.0 days. Currently, 8.6% of the shares of the company are short sold.
View Tenet Healthcare's Short Interest
.

Who are some of Tenet Healthcare's key competitors?

What other stocks do shareholders of Tenet Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tenet Healthcare investors own include Micron Technology (MU), Alibaba Group (BABA), Advanced Micro Devices (AMD), Walt Disney (DIS), Delta Air Lines (DAL), General Electric (GE), Netflix (NFLX), Bank of America (BAC), Intel (INTC) and NVIDIA (NVDA).

Who are Tenet Healthcare's key executives?

Tenet Healthcare's management team includes the following people:
  • Mr. Ronald A. Rittenmeyer, Exec. Chairman & CEO (Age 72)
  • Mr. Daniel J. Cancelmi, Chief Financial Officer (Age 56)
  • Ms. Audrey T. Andrews, Sr. VP & Gen. Counsel (Age 52)
  • Mr. Keith B. Pitts, Vice Chairman (Age 61)
  • Mr. Saumya Sutaria M.D., Chief Operating Officer (Age 46)

What is Tenet Healthcare's stock symbol?

Tenet Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "THC."

Who are Tenet Healthcare's major shareholders?

Tenet Healthcare's stock is owned by a variety of institutional and retail investors. Top institutional investors include Letko Brosseau & Associates Inc. (2.77%), Goldman Sachs Group Inc. (1.73%), Bank of New York Mellon Corp (1.26%), Columbus Hill Capital Management L.P. (0.76%), Victory Capital Management Inc. (0.47%) and LSV Asset Management (0.45%). Company insiders that own Tenet Healthcare stock include Audrey T Andrews, Daniel J Cancelmi, Edward A Kangas, Glenview Capital Management, L, Marie Quintana, Nadja West, Ronald A Rittenmeyer and Saumya Sutaria.
View institutional ownership trends for Tenet Healthcare
.

Which major investors are selling Tenet Healthcare stock?

THC stock was sold by a variety of institutional investors in the last quarter, including Federated Hermes Inc., Prudential Financial Inc., State of Tennessee Treasury Department, Mackay Shields LLC, Amalgamated Bank, HighTower Advisors LLC, Texas Permanent School Fund, and Bowling Portfolio Management LLC. Company insiders that have sold Tenet Healthcare company stock in the last year include Audrey T Andrews, and Edward A Kangas.
View insider buying and selling activity for Tenet Healthcare
.

Which major investors are buying Tenet Healthcare stock?

THC stock was purchased by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Columbus Hill Capital Management L.P., Letko Brosseau & Associates Inc., Victory Capital Management Inc., Marble Ridge Capital LP, State of Wisconsin Investment Board, Bank of New York Mellon Corp, and Assenagon Asset Management S.A.. Company insiders that have bought Tenet Healthcare stock in the last two years include Daniel J Cancelmi, Glenview Capital Management, L, Marie Quintana, Nadja West, Ronald A Rittenmeyer, and Saumya Sutaria.
View insider buying and selling activity for Tenet Healthcare
.

How do I buy shares of Tenet Healthcare?

Shares of THC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Tenet Healthcare's stock price today?

One share of THC stock can currently be purchased for approximately $29.30.

How big of a company is Tenet Healthcare?

Tenet Healthcare has a market capitalization of $3.09 billion and generates $18.48 billion in revenue each year. The company earns $-232,000,000.00 in net income (profit) each year or $2.68 on an earnings per share basis. Tenet Healthcare employs 113,600 workers across the globe.

What is Tenet Healthcare's official website?

The official website for Tenet Healthcare is www.tenethealth.com.

How can I contact Tenet Healthcare?

Tenet Healthcare's mailing address is 14201 Dallas Parkway, DALLAS TX, 75254. The company can be reached via phone at 469-893-2200 or via email at [email protected]

This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.